WebFeb 1, 2024 · Description and Brand Names. Drug information provided by: IBM Micromedex US Brand Name. Phesgo; Descriptions. Pertuzumab, trastuzumab, and hyaluronidase-zzxf combination injection is used first together with other cancer medicines to treat HER2-positive, locally advanced, inflammatory, or early stage breast cancer (either greater than … WebPhesgo® contains two separate monoclonal antibodies, trastuzumab and pertuzumab. Previously, trastuzumab and pertuzumab were used separately or in combination to provide anti-cance r treatment. Phesgo® combined these two separate monoclonal antibodies into a single injection for use.
Trastuzumab and pertuzumab Macmillan Cancer Support
WebNov 16, 2024 · PHESGO is a combination of pertuzumab, trastuzumab, and hyaluronidase. Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II ... 12 CLINICAL PHARMACOLOGY WebMar 16, 2024 · Heart problems. Treatment with Phesgo may affect the heart. Talk to your doctor, pharmacist or nurse before you are given Phesgo if: you have ever had heart … mini champagne glasses wedding favors
PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) A Treatm…
WebJun 29, 2024 · The FDA has approved Phesgo, an injection of Herceptin, Perjeta, and hyaluronidase-zzxf to treat HER2-positive breast cancer in combination with chemotherapy. ... Anaphylaxis is a severe allergic reaction that can cause hives, low blood pressure, dizziness, chills, and trouble breathing. The healthcare provider who gives you the Phesgo ... WebNov 30, 2024 · bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, … WebJul 10, 2024 · Phesgo (Hyaluronidase Pertuzumab and Trastuzumab) Generic Name: Hyaluronidase, pertuzumab, and trastuzumab Reviewed: July 10, 2024 Hyaluronidase, … most hassle free cars